Personalized Medicine Using Neuroimmunological Biomarkers in Depressive Disorders.

J Pers Med · 2021 · PMC7916349 · PMID 33578686

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendp = 0.06so close (0.05 < p ≤ 0.1)

Logistic regression on the training dataset showed that a model including the count of CRP > 3 mg/L showed a trend to better predict probable MDD than a baseline model including only sex, lifetime smoking, and body mass index ( p = 0.06).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.